Dupont APC Blood Collection Container With Thromboplastin
510(k) K942241
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK942241 | Date18 Aug 1994 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- JKA
- Device Class
- Class II
- Regulation
- 21 CFR Part 862.1675
- Advisory Committee
- Clinical Chemistry
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 22 Sep 2026
This device is a blood collection container with thromboplastin, classified under the nomenclature for tubes, vials, systems, serum separators, and blood collection devices. It is designed for the collection and processing of blood specimens in clinical laboratory settings.
The device is supplied as a single-use container and was cleared via the FDA 510(k) process under K942241, with a decision of substantially equivalent granted on August 18, 1994. It is intended for use in clinical chemistry laboratories and is not MRI conditional or reusable; storage and handling should follow standard procedures for blood collection devices as indicated by its authorization and specifications.
Other devices from Dupont Medical Products
Questions
AI-generated answers, 22 Sep 2026
What is the Dupont APC Blood Collection Container with Thromboplastin used for?
It is designed for the collection and processing of blood specimens in clinical laboratory settings, specifically intended for use in clinical chemistry laboratories to support diagnostic testing.
Is the Dupont APC Blood Collection Container with Thromboplastin reusable or single-use?
The device is supplied as a single-use container and is not intended for reuse; it should be discarded after one use to maintain specimen integrity and prevent cross-contamination.
How was the Dupont APC Blood Collection Container with Thromboplastin cleared for market?
It was cleared via the FDA 510(k) process under submission K942241, with a determination of substantial equivalence granted on August 18, 1994, based on its similarity to legally marketed predicate devices.
What storage and handling procedures should be followed for this device?
Storage and handling should follow standard procedures for blood collection devices as indicated by its authorization and specifications, typically involving controlled temperature and protection from light and moisture until use.